# Ali Behbahani

Ali Behbahani of Littleton, CO appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. 26 filing roles across Form D (25), Form ADV (1).

## Filings (26)

| Filed | Source | Entity | Role | Location |
| --- | --- | --- | --- | --- |
| 2025-03-31 | Form ADV | [GOODFINCH MANAGEMENT, LLC](https://search.stillhousedata.com/firm/309789) | MANAGER | SAN FRANCISCO, CA |
| 2016-08-09 | Form D | [ROTATION MEDICAL INC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1387966&type=&dateb=&owner=include&count=40) | Director | PLYMOUTH, MN |
| 2020-05-26 | Form D | [MINERVA SURGICAL INC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1452965&type=&dateb=&owner=include&count=40) | Director | Santa Clara, CA |
| 2020-08-03 | Form D | [GENOCEA BIOSCIENCES, INC.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1457612&type=&dateb=&owner=include&count=40) | Director | CAMBRIDGE, MA |
| 2017-01-23 | Form D | [Ivantis, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1521993&type=&dateb=&owner=include&count=40) | Director | IRVINE, CA |
| 2014-03-18 | Form D | [Oculeve, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1533518&type=&dateb=&owner=include&count=40) | Director | SAN FRANCISCO, CA |
| 2014-10-02 | Form D | [Adaptimmune Ltd](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1621227&type=&dateb=&owner=include&count=40) | Director | ABINGDON, OXFORDSHIRE, X0 |
| 2021-10-04 | Form D | [Cardionomic, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1655807&type=&dateb=&owner=include&count=40) | Director | New Brighton, MN |
| 2020-04-10 | Form D | [CRISPR Therapeutics AG](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1674416&type=&dateb=&owner=include&count=40) | Director | Zug, V6 |
| 2019-03-01 | Form D | [New Enterprise Associates 17, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1768564&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2025-06-05 | Form D | [SpyGlassPharma, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1778922&type=&dateb=&owner=include&count=40) | Director | ALISO VIEJO, CA |
| 2019-09-06 | Form D | [Nkarta, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1787400&type=&dateb=&owner=include&count=40) | Director | SOUTH SAN FRANCISCO, CA |
| 2023-02-06 | Form D | [Arcellx, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1786205&type=&dateb=&owner=include&count=40) | Director | GAITHERSBURG, MD |
| 2019-12-19 | Form D | [NEA BH SPV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1794978&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2024-07-11 | Form D | [858 Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1806356&type=&dateb=&owner=include&count=40) | Director | SAN DIEGO, CA |
| 2021-03-24 | Form D | [Monte Rosa Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1826457&type=&dateb=&owner=include&count=40) | Director | BOSTON, MA |
| 2020-09-04 | Form D | [NEA BH SPV II, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1822990&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2022-04-22 | Form D | [FirstLight Bio, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1924340&type=&dateb=&owner=include&count=40) | Director | NEW YORK, NY |
| 2022-12-30 | Form D | [Launchpad Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1959206&type=&dateb=&owner=include&count=40) | Director | CAMBRIDGE, MA |
| 2026-03-27 | Form D | [Nexo Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1955319&type=&dateb=&owner=include&count=40) | Related Person | LITTLETON, CO |
| 2025-06-25 | Form D | [NEA SH SPV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1974230&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2024-02-23 | Form D | [NEA RP SPV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2009639&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2024-08-02 | Form D | [NEA TS 2024 SPV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2025469&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2024-05-21 | Form D | [NEA CH SPV, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2022095&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2024-07-18 | Form D | [NEA Secondary Opportunity Fund, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2029309&type=&dateb=&owner=include&count=40) | Executive Officer | TIMONIUM, MD |
| 2025-01-24 | Form D | [Tune Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2053139&type=&dateb=&owner=include&count=40) | Director | SEATTLE, WA |


---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.